CROSSWALK: FFS Annual Surveys

C

ha
ng
e

Ch
an
ge

Bu
rd
en

fo
r
ea
so
n
R

Ty
pe
of
C

ha
ng
e

sio
n)
ve
r
(n
ew
20
24
Updated grammar and formatting of questions for easier
understanding.

Rev

To make it easier for respondent to complete the survey. Updated
grammar, sentence structure and formatting for easier understanding.

Decrease work burden for respondents by 5 min.

Spelled out acronyms for easier understanding.

Rev

To make it easier for respondent to complete the survey by identifying
acronyms.

Decrease work burden for respondents by 5 min.

Opening Introduction to survey: CMS does not edit State
responses; therefore, what is submitted will be what is
posted on Medicaid.gov. This material is also utilized for
composing the annual report to Congress.

Add

Incorporated statement in introduction to increase respondent
understanding that their responses will not be altered when reporting out.

No burden change.

Section I, Demographics - removed telephone number

Rev

Removed telephone number as not needed and replaced with Postion Title No burden change.

Section I. Demographics, Question 2. question clarified

Rev

Question revised for ease of understanding to the respondent.

Decrease work burden for respondents by 10 min.

Section II. ProDUR, Question 1.b. Added aditional response

Add

Documented explanation required for this question.

Increase work burden for respondents by 5 min.

Section II. ProDUR, Question 2, question clarified

Rev

Question revised for ease of understanding to the respondent.

Decrease work burden for respondents by 5 min.

Section II. ProDUR, Question 4. "No" explanation required.

Add

Documented explanation required for this question.

Increase work burden for respondents by 10 min.

Section II. ProDUR, Question 9. Does your system have a
diagnosis edit that can be utilized when processing a
prescription? Please explain.

Add

Querying respondents to confirm that a diagnosis edit is included in their
DUR criteria as diagnoses play an important role for FDA approved
indications for drugs.

Increase work burden for respondents by 10 min.

Section II. ProDUR, Question 10, question clarified

Rev

Question revised for ease of understanding to the respondent.

Decrease work burden for respondents by 5 min.

Rev

Clarification.

No burden change.

Add

Added this subpart question to provide oversight to requirements.

Increase work burden for respondents by 15 min.

Section II. ProDUR, Question 11, Table 1 - NOTE: If an
entry is not included in the drop-down box list, please select
‘other’ at end of the list and enter a free form response in
the box below.
Section II. ProDUR, Question 12, Added subpart question
for oversight - Please explain the steps taken by the State
Agency to monitor compliance by pharmacies with the
prospective DUR counseling requirements contained in
Federal and State laws and regulations

Type of Change: Rev = Revision, Del = Deletion, Add = Addition, and Red = Redesignation.

Section VI. Generic Policy and Utilization Data, Question 4.
How many multi-source drugs have the innovator as the
preferred drug product based on net pricing (brand
preferred over generic)?
Section VII. Program Evaluation/Cost Savings/Cost
Avoidance, Question 4. Does your Medicaid program
provide coverage of over-the-counter medications when
prescribed by an authorized prescriber?

Rev

For Clarity

Decrease work burden for respondents by 15 min.

Rev

Updated for clarification

Increase work burden for respondents by 10 min.

Section VIII. FWA, A. Lock-in or PRR, Question 1.

Add

The "No" response requires an explanation.

Increase work burden for respondents by 10 min.

Section VIII. FWA, A. Question 2.e. Revision

Rev

Updated question for ease of understanding and response option of n/a to
decrease workload.

Decrease work burden for respondents by 20 min.

Section VIII. FWA, A. Added Question - Briefly explain the
States’ objectives and scope of responsibility between DUR
and SUR functions as they relate to FWA. Additionally,
explain how the State maintains separation between fraud
and abuse and educational activities. (Character limit
1000)

Add

Added question to maintain oversight to requirements.

Increase work burden for respondents by 20 min.

Section VIII. FWA, B. PDMP - Section reorganized as
mandatory reporting is required with FFY 2023 data.

Rev

To more efficiently follow the flow of Section 5042 of the SUPPORT Act
Increase work burden for respondents by 25 min.
mandatory DUR questions.

Section VIII. FWA, B. PDMP - Removed Question 1. d.

Del

Question not relevent to SUPPORT Act Section 5042

Decrease work burden for respondents by 10 min.

Section VIII. FWA, B. PDMP - Question 3

Rev

Question clarification

No burden change.

Section VIII. FWA, B. PDMP - Added Question 4.c.i.

Add

Added sub part question for clarity

Increase work burden for respondents by 5 min.

Section VIII. FWA, B. PDMP - Updated Questions 4. d., e.,
f. and g

Rev

Updated questions for clarity and understanding

No burden change.

Section VIII. FWA, B. PDMP - Added Question 4.j. Has
your State exempted certain individuals, (see the definition
of Covered Individuals under section 1944(h)(2) of the Act,
as added by Section 5042 of the SUPPORT Act), from the

Add

Adding additional question to follow Section 5042 of the SUPPORT Act.

Increase work burden for respondents by 10 min.

Section VIII. FWA, C. Opioids - Revision Question 2. Does
your state have POS edits in place to limit the quantity
dispensed of opioids?

Rev

Text revision for ease and clarity of responses.

No burden change.

Section VIII. FWA, C. Opioids, Question 2.a

Del

Text revision for ease and clarity of responses.

Decrease work burden for respondents by 5 min.

Type of Change: Rev = Revision, Del = Deletion, Add = Addition, and Red = Redesignation.

Section VIII. FWA, C. Opioids, Question 2.b

Del

Text revision for ease and clarity of responses.

Decrease work burden for respondents by 5 min.

Section VIII. FWA, C. Opioids - Question 7. Removed
"Yes" POS Edits.

Rev

For clarity.

Decrease work burden for respondents by 5 min.

Section VIII. FWA, C. Opioids - Question 8. Removed
"Yes" explanation.

Rev

For clarity.

Decrease work burden for respondents by 5 min.

Section VIII. FWA, C. Opioids - Question 9. Removed
"Yes" explanation.

Rev

For clarity.

Decrease work burden for respondents by 5 min.

Section VIII. FWA, C. Opioids - Question 10. Does your
state have POS safety edits or perform automated
respective claims review and/or provider education in
regard to beneficiaries with a diagnosis or history of opioid

Rev

Text revision for ease and clarity of responses.

Decrease work burden for respondents by 10 min.

Section VIII. FWA, C. Opioids - Question 11 - Updated to
current reference

Rev

Clinical Practice Guideline for Prescribing Opioids for Pain reference
updated from 2016 to 2022

No burden change.

Section VIII. FWA, C. Opioids - Question 12, "No"
explanation required.

Add

Documented explanation required for this question.

Increase work burden for respondents by 10 min.

Section VIII. FWA, C. Opioids - Question 13

Rev

For clarity. COVID-19 removed as no longer public emergency.

No burden change.

Section VIII. FWA, D. MME - Question 1.a - Revised
response options

Rev

Revised response options for better detail

no burden change.

Section VIII. FWA, D. MME - Question 1.b - Clarified
question

Rev

Clarified question for ease of undestanding

no burden change.

Section VIII. FWA, D. MME - Question 2. "No" explanation
required.

Add

Documented explanation required for this question.

Increase work burden for respondents by 10 min.

Section VIII. FWA, E. OUD - Question 1. "No" explanation
required.

Add

Documented explanation required for this question.

Increase work burden for respondents by 10 min.

Section VIII. FWA, E. OUD - Question 8. Updated

Rev

Text revision for ease and clarity for response.

No burden change.

Section VIII. FWA, G. Psychotropic Medication - Questions
3 and 4 added

Add

Added to comply with 2024 CAA Section 203 requirement

Increase work burden for respondents by 20min.

Type of Change: Rev = Revision, Del = Deletion, Add = Addition, and Red = Redesignation.

Section VIII. FWA, G. Psychotropic Medication - Questions
2.a.b. / 6.a b. / 7.a.b. / 8.a.b. / 9.a.b.

Rev

Clarified these related questions for ease of understanding

Decrease work burden for respondents by 5 min.

Section X. Managed Care Organizations - Question 2.
Update Partial responses.

Rev

Text revision for ease and clarity of responses.

Increase work burden for respondents by 5 min.

Total:

Increased workload by 60 minutes

Type of Change: Rev = Revision, Del = Deletion, Add = Addition, and Red = Redesignation.